MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
7.50
-0.11 (-1.45%)
Apr 24, 2025, 4:00 PM EDT - Market closed
MiNK Therapeutics Market Cap
MiNK Therapeutics has a market cap or net worth of $30.54 million as of April 25, 2025. Its market cap has decreased by -12.85% in one year.
Market Cap
30.54M
Enterprise Value
30.89M
1-Year Change
-12.85%
Ranking
Category
Stock Price
$7.50
Market Cap Chart
Since the IPO on October 15, 2021, MiNK Therapeutics's market cap has decreased from $386.36M to $30.54M, a decrease of -92.10%. That is a compound annual growth rate of -51.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2025 | 29.75M | 7.71% |
| Dec 31, 2024 | 27.62M | -25.23% |
| Dec 29, 2023 | 36.94M | -58.11% |
| Dec 30, 2022 | 88.18M | -40.99% |
| Dec 31, 2021 | 149.43M | -61.32% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 777.78B |
| UnitedHealth Group | 375.92B |
| Johnson & Johnson | 368.88B |
| AbbVie | 324.32B |
| Novo Nordisk | 276.96B |
| Abbott Laboratories | 222.43B |
| AstraZeneca | 215.41B |
| Novartis AG | 210.89B |